Announcement on Implementation of Dividend Distribution for 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for 2025
Filed with SSE · · 6 pages · Chinese
Release
Sichuan Huiyu Pharmaceutical Co. Ltd. on 6ix
Earlier from Sichuan Huiyu Pharmaceutical
- Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale
- Announcement on Progress in Providing Guarantees for Wholly-owned Subsidiaries
- Announcement on Election of Employee Representative Directors for the 3rd Board of Directors
- Publicity Description and Verification Opinions of the Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Objects in the 2026 Restricted Stock Incentive Plan
- Announcement on Rotary Freezing of Shares Held by Shareholder with Over 5% Shares
Later from Sichuan Huiyu Pharmaceutical
- Announcement on Voluntary Disclosure of Notice of Acceptance for Drug Clinical Trial Obtained by HY07121 Injection (Subcutaneous Injection)
- Announcement on Change of Sponsor Representative
- Announcement on Voluntary Disclosure of Obtaining Overseas Marketing Authorization for the Company's Product
- Announcement on Initially Granting Restricted Stocks to Incentive Objects of the 2026 Restricted Stock Incentive Plan
- Announcement on Voluntary Disclosure of HY-1016 Sustained-release Injection Obtaining Notice of Approval for Drug Clinical Trial
Follow Sichuan Huiyu Pharmaceutical into a list and get an email when it puts out news.
Follow Sichuan Huiyu Pharmaceutical